Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline

STUDY OBJECTIVE: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline recommends a maximally-tolerated statin with add-on lipid-lowering therapy, ezetimibe and/or proprotein convertase subtilisin/kexin type 9 (PCSK9) for adults with very-high atheroscler...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanaeme, Chibuike J., Bittner, Vera, Brown, Todd M., Colantonio, Lisandro D., Dhalwani, Nafeesa, Jones, Jenna, Kalich, Bethany, Exter, Jason, Jackson, Elizabeth A., Levitan, Emily B., Poudel, Bharat, Wang, Zhixin, Woodward, Mark, Muntner, Paul, Rosenson, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168648/
https://www.ncbi.nlm.nih.gov/pubmed/37168932
http://dx.doi.org/10.1016/j.ahjo.2022.100201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168648/
https://www.ncbi.nlm.nih.gov/pubmed/37168932
http://dx.doi.org/10.1016/j.ahjo.2022.100201

Ejemplares similares